BREAKTHROUGH R&D

Heartland Herbal Biotech is advancing a differentiated R&D platform focused on prescription-grade cannabis therapeutics.The program combines discovery of proprietary cannabinoid-derived molecules with innovative drug-delivery technologies.Led by an experienced pharmaceutical development team, the strategy is strengthened through strategic industry and research partnerships.This approach positions the company to deliver scalable, high-value clinical solutions in a rapidly expanding global medical cannabis market.

Heartland Herbal Biotech’s innovation program is structured around three key pillars

High-THC API

USA specialty prescription cannabis medicines

Partnerships for licenced drugs

Heartland Herbal Biotech has a team of experienced scientiest that gives us a strategic advantage clinical development and long-term value creation.

The epidemic, which has evolved from a crisis of prescription painkillers to one dominated by illicit synthetic opioids, has had a profound impact on families, communities, and the economy, with estimated annual costs exceeding $500 billion.

With projected U.S. market potential exceeding 500 billion dollars of profound impact to the overall economy, Heartlands Herbal Biotech is position to be on the Frontier of producing pharmaceutical grade replacement precipition drugs for opiods usage.

The company was an early strategic investor in the Oklahoma Cannabis medical adoption.